无标记电化学S100B免疫传感器用于创伤性脑损伤生物标志物灵敏检测
该研究构建了一种基于金纳米颗粒-还原氧化石墨烯(AuNPs-rGO)修饰玻碳电极的无标记电化学免疫传感器,用于血清S100B的定量检测。传感器在0.75-75,000 pg mL-1范围内线性检测S100B,检测限为1.31 pg mL-1,与其它S100家族蛋白无交叉反应,加标血清回收率为93.33-106.64%。
要点
- 传感器检测S100B的线性范围为0.75-75,000 pg mL-1,检测限1.31 pg mL-1。
- 与其它S100家族蛋白无交叉反应,选择性良好。
- S100B加标血清回收率为93.33-106.64%,重现性和稳定性良好。
核心结论
- 该无标记电化学免疫传感器可灵敏、特异性地检测血清S100B,有望用于TBI患者的快速检测。
研究设计与样本
- 研究构建了基于AuNPs-rGO修饰玻碳电极的无标记电化学免疫传感器,用于血清S100B检测。
- 采用扫描电子显微镜、循环伏安法和阻抗谱对电极修饰步骤进行表征。
- 采用快速傅里叶变换方波伏安法(FFT-SWV)测定峰电流变化与S100B浓度的关系。
主要发现
- 传感器检测S100B的线性范围为0.75-75,000 pg mL-1,检测限为1.31 pg mL-1。
- 与其它干扰性S100家族蛋白无交叉反应,选择性和特异性良好。
- S100B加标血清的回收率为93.33-106.64%,重现性和稳定性良好。
关键数值与推荐
- 线性范围0.75-75,000 pg mL-1,检测限1.31 pg mL-1。
- 加标血清回收率93.33-106.64%。
临床怎么用
- 该传感器分析性能良好,有望作为TBI患者血清S100B快速检测的工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
S100B protein is an established biomarker related to prognosis in traumatic brain injury (TBI). Developing sensitive methods for the serum S100B quantification is clinically valuable. This paper proposes a simple label-free electrochemical TBI-immunosensor for the timely detection of S100B in the sera of TBI patients. In the first step of bioelectrode fabrication, gold nanoparticles-reduced graphene oxide (AuNPs-rGO) nanocomposite was layered onto a glassy carbon electrode (GCE) to improve the amplification of electrochemical signals. The anti-S100B was immobilized onto a modified-GCE via self-assembly monolayers using 11-Mercaptoundecanoic acid and EDC-NHS. Electrochemical immunoassay was planned based on forming of an immunocomplex bioaccumulation among S100B and anti-S100B, resulting in a decline peak current in the [Fe (CN)6]3-/4- redox couple. The modification steps of immobilization were morphologically or electrochemically characterized by scanning electron microscopy, cyclic voltammetry, and impedance spectroscopy techniques. A fast Fourier transform square wave voltammetry was applied to peak current change in accordance with the concentration of S100B under optimal experimental conditions. The fabricated immunosensor detected sensitively the S100B in the linear range of 0.75-75,000 pg mL-1, with a detection limit of 1.31 pg mL-1, which comprises the whole biosynthesis broad of S100B in healthy and TBI patients. Likewise, no cross-reactivity was observed with other interfering S100 family proteins, denoting the excellent selectivity and specificity. Moreover, good reproducibility and stability were obtained for the fabricated immunosensor. Immunosensor performance for S100B-spiked serum exhibited a recovery range of 93.33-106.64%. Given its analytical performance, this immunosensor shows promise as a tool for rapid serum S100B measurement in patients with TBI.
引用
- Borumand MR, Mojtahedzadeh M, Hassani S, et al. The label-free electrochemical S100B-TBI immunosensor for sensitive detection of S100B protein as a biomarker for traumatic brain injury using FFT-SWV voltammetry. Clin Chim Acta. 2026. PMID: 41839327. doi:10.1016/j.cca.2026.120964
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。